Crohn's Disease Ph III study
Research payments
$108,100
Through program year 2020, $108,100 in research payments was reported against Crohn's Disease Ph III study, across 153 payments, paid by Boehringer Ingelheim International GmbH.
- Paid by
- Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $7,960 | 4 |
| 2019 | Research | $100,140 | 149 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Suzy Kim Greenville, SC Named on 55 payments
- Jennifer Vincent Temple, TX Named on 12 payments
- Tuba Esfandyari Kansas City, KS Named on 8 payments
- Keith Friedenberg Mentor, OH Named on 8 payments
- Charles Berkelhammer Oak Lawn, IL Named on 7 payments
- Mahmudul Haq Kissimmee, FL Named on 6 payments
- Jaleel Durrani Louisville, KY Named on 6 payments
- Andria Mushahwar Maitland, FL Named on 5 payments
- Louis Korman Chevy Chase, MD Named on 5 payments
- Gerald Dryden Louisville, KY Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.